Japan Opioids Drug Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin ), hydrocodone (Vicodin ), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.

    This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Opioids Drug market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Opioids Drug market. Detailed analysis of key players, along with key growth strategies adopted by Opioids Drug industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • J&J

    • Vistapharm

    • Purdue Pharma

    • Pfizer

    • Mylan

    • Hikma

    • INSYS

    • Endo

    • Egalet

    • Depomed

    • Teva

    • Pernix

    • Mallinckrodt

    By Type:

    • Oxycodone

    • Hydromorphone

    • Codeine

    • Fentanyl

    • Others

    By End-User:

    • Pain Relief

    • Anesthesia

    • Others

    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Opioids Drug Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Opioids Drug Market Size and Growth Rate of Oxycodone from 2014 to 2026

      • 1.3.2 Japan Opioids Drug Market Size and Growth Rate of Hydromorphone from 2014 to 2026

      • 1.3.3 Japan Opioids Drug Market Size and Growth Rate of Codeine from 2014 to 2026

      • 1.3.4 Japan Opioids Drug Market Size and Growth Rate of Fentanyl from 2014 to 2026

      • 1.3.5 Japan Opioids Drug Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Market Size and Growth Rate of Pain Relief

      • 1.4.2 Market Size and Growth Rate of Anesthesia

      • 1.4.3 Market Size and Growth Rate of Others

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Opioids Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Opioids Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Opioids Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Opioids Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Opioids Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Opioids Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Opioids Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Opioids Drug Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Opioids Drug Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Opioids Drug by Major Types

      • 3.4.1 Japan Opioids Drug Market Size and Growth Rate of Oxycodone from 2014 to 2026

      • 3.4.2 Japan Opioids Drug Market Size and Growth Rate of Hydromorphone from 2014 to 2026

      • 3.4.3 Japan Opioids Drug Market Size and Growth Rate of Codeine from 2014 to 2026

      • 3.4.4 Japan Opioids Drug Market Size and Growth Rate of Fentanyl from 2014 to 2026

      • 3.4.5 Japan Opioids Drug Market Size and Growth Rate of Others from 2014 to 2026

    4 Segmentation of Opioids Drug Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Opioids Drug by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Opioids Drug in Pain Relief

      • 4.4.2 Market Size and Growth Rate of Opioids Drug in Anesthesia

      • 4.4.3 Market Size and Growth Rate of Opioids Drug in Others

    5 Market Analysis by Regions

    • 5.1 Japan Opioids Drug Production Analysis by Regions

    • 5.2 Japan Opioids Drug Consumption Analysis by Regions

    6 Hokkaido Opioids Drug Landscape Analysis

    • 6.1 Hokkaido Opioids Drug Landscape Analysis by Major Types

    • 6.2 Hokkaido Opioids Drug Landscape Analysis by Major End-Users

    7 Tohoku Opioids Drug Landscape Analysis

    • 7.1 Tohoku Opioids Drug Landscape Analysis by Major Types

    • 7.2 Tohoku Opioids Drug Landscape Analysis by Major End-Users

    8 Kanto Opioids Drug Landscape Analysis

    • 8.1 Kanto Opioids Drug Landscape Analysis by Major Types

    • 8.2 Kanto Opioids Drug Landscape Analysis by Major End-Users

    9 Chubu Opioids Drug Landscape Analysis

    • 9.1 Chubu Opioids Drug Landscape Analysis by Major Types

    • 9.2 Chubu Opioids Drug Landscape Analysis by Major End-Users

    10 Kinki Opioids Drug Landscape Analysis

    • 10.1 Kinki Opioids Drug Landscape Analysis by Major Types

    • 10.2 Kinki Opioids Drug Landscape Analysis by Major End-Users

    11 Chugoku Opioids Drug Landscape Analysis

    • 11.1 Chugoku Opioids Drug Landscape Analysis by Major Types

    • 11.2 Chugoku Opioids Drug Landscape Analysis by Major End-Users

    12 Shikoku Opioids Drug Landscape Analysis

    • 12.1 Shikoku Opioids Drug Landscape Analysis by Major Types

    • 12.2 Shikoku Opioids Drug Landscape Analysis by Major End-Users

    13 Kyushu Opioids Drug Landscape Analysis

    • 13.1 Kyushu Opioids Drug Landscape Analysis by Major Types

    • 13.2 Kyushu Opioids Drug Landscape Analysis by Major End-Users

    14 Major Players Profiles

    • 14.1 J&J

      • 14.1.1 J&J Company Profile and Recent Development

      • 14.1.2 J&J Market Performance

      • 14.1.3 J&J Product and Service Introduction

    • 14.2 Vistapharm

      • 14.2.1 Vistapharm Company Profile and Recent Development

      • 14.2.2 Vistapharm Market Performance

      • 14.2.3 Vistapharm Product and Service Introduction

    • 14.3 Purdue Pharma

      • 14.3.1 Purdue Pharma Company Profile and Recent Development

      • 14.3.2 Purdue Pharma Market Performance

      • 14.3.3 Purdue Pharma Product and Service Introduction

    • 14.4 Pfizer

      • 14.4.1 Pfizer Company Profile and Recent Development

      • 14.4.2 Pfizer Market Performance

      • 14.4.3 Pfizer Product and Service Introduction

    • 14.5 Mylan

      • 14.5.1 Mylan Company Profile and Recent Development

      • 14.5.2 Mylan Market Performance

      • 14.5.3 Mylan Product and Service Introduction

    • 14.6 Hikma

      • 14.6.1 Hikma Company Profile and Recent Development

      • 14.6.2 Hikma Market Performance

      • 14.6.3 Hikma Product and Service Introduction

    • 14.7 INSYS

      • 14.7.1 INSYS Company Profile and Recent Development

      • 14.7.2 INSYS Market Performance

      • 14.7.3 INSYS Product and Service Introduction

    • 14.8 Endo

      • 14.8.1 Endo Company Profile and Recent Development

      • 14.8.2 Endo Market Performance

      • 14.8.3 Endo Product and Service Introduction

    • 14.9 Egalet

      • 14.9.1 Egalet Company Profile and Recent Development

      • 14.9.2 Egalet Market Performance

      • 14.9.3 Egalet Product and Service Introduction

    • 14.10 Depomed

      • 14.10.1 Depomed Company Profile and Recent Development

      • 14.10.2 Depomed Market Performance

      • 14.10.3 Depomed Product and Service Introduction

    • 14.11 Teva

      • 14.11.1 Teva Company Profile and Recent Development

      • 14.11.2 Teva Market Performance

      • 14.11.3 Teva Product and Service Introduction

    • 14.12 Pernix

      • 14.12.1 Pernix Company Profile and Recent Development

      • 14.12.2 Pernix Market Performance

      • 14.12.3 Pernix Product and Service Introduction

    • 14.13 Mallinckrodt

      • 14.13.1 Mallinckrodt Company Profile and Recent Development

      • 14.13.2 Mallinckrodt Market Performance

      • 14.13.3 Mallinckrodt Product and Service Introduction

     

    The List of Tables and Figures (Totals 99 Figures and 130 Tables)

    • Figure Japan Opioids Drug Market Size and Growth Rate of Oxycodone from 2014 to 2026

    • Figure Japan Opioids Drug Market Size and Growth Rate of Hydromorphone from 2014 to 2026

    • Figure Japan Opioids Drug Market Size and Growth Rate of Codeine from 2014 to 2026

    • Figure Japan Opioids Drug Market Size and Growth Rate of Fentanyl from 2014 to 2026

    • Figure Japan Opioids Drug Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Market Size and Growth Rate of Pain Relief

    • Figure Market Size and Growth Rate of Anesthesia

    • Figure Market Size and Growth Rate of Others

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Opioids Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Opioids Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Opioids Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Opioids Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Opioids Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Opioids Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Opioids Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Opioids Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Opioids Drug Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Opioids Drug

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Opioids Drug by Different Types from 2014 to 2026

    • Table Consumption Share of Opioids Drug by Different Types from 2014 to 2026

    • Figure Japan Opioids Drug Market Size and Growth Rate of Oxycodone from 2014 to 2026

    • Figure Japan Opioids Drug Market Size and Growth Rate of Hydromorphone from 2014 to 2026

    • Figure Japan Opioids Drug Market Size and Growth Rate of Codeine from 2014 to 2026

    • Figure Japan Opioids Drug Market Size and Growth Rate of Fentanyl from 2014 to 2026

    • Figure Japan Opioids Drug Market Size and Growth Rate of Others from 2014 to 2026

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Opioids Drug by Different End-Users from 2014 to 2026

    • Table Consumption Share of Opioids Drug by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Pain Relief

    • Figure Market Size and Growth Rate of Anesthesia

    • Figure Market Size and Growth Rate of Others

    • Table Japan Opioids Drug Production by Regions

    • Table Japan Opioids Drug Production Share by Regions

    • Figure Japan Opioids Drug Production Share by Regions in 2014

    • Figure Japan Opioids Drug Production Share by Regions in 2018

    • Figure Japan Opioids Drug Production Share by Regions in 2026

    • Table Japan Opioids Drug Consumption by Regions

    • Table Japan Opioids Drug Consumption Share by Regions

    • Figure Japan Opioids Drug Consumption Share by Regions in 2014

    • Figure Japan Opioids Drug Consumption Share by Regions in 2018

    • Figure Japan Opioids Drug Consumption Share by Regions in 2026

    • Table Hokkaido Opioids Drug Consumption by Types from 2014 to 2026

    • Table Hokkaido Opioids Drug Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Opioids Drug Consumption Share by Types in 2014

    • Figure Hokkaido Opioids Drug Consumption Share by Types in 2018

    • Figure Hokkaido Opioids Drug Consumption Share by Types in 2026

    • Table Hokkaido Opioids Drug Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Opioids Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Opioids Drug Consumption Share by End-Users in 2014

    • Figure Hokkaido Opioids Drug Consumption Share by End-Users in 2018

    • Figure Hokkaido Opioids Drug Consumption Share by End-Users in 2026

    • Table Tohoku Opioids Drug Consumption by Types from 2014 to 2026

    • Table Tohoku Opioids Drug Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Opioids Drug Consumption Share by Types in 2014

    • Figure Tohoku Opioids Drug Consumption Share by Types in 2018

    • Figure Tohoku Opioids Drug Consumption Share by Types in 2026

    • Table Tohoku Opioids Drug Consumption by End-Users from 2014 to 2026

    • Table Tohoku Opioids Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Opioids Drug Consumption Share by End-Users in 2014

    • Figure Tohoku Opioids Drug Consumption Share by End-Users in 2018

    • Figure Tohoku Opioids Drug Consumption Share by End-Users in 2026

    • Table Kanto Opioids Drug Consumption by Types from 2014 to 2026

    • Table Kanto Opioids Drug Consumption Share by Types from 2014 to 2026

    • Figure Kanto Opioids Drug Consumption Share by Types in 2014

    • Figure Kanto Opioids Drug Consumption Share by Types in 2018

    • Figure Kanto Opioids Drug Consumption Share by Types in 2026

    • Table Kanto Opioids Drug Consumption by End-Users from 2014 to 2026

    • Table Kanto Opioids Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Opioids Drug Consumption Share by End-Users in 2014

    • Figure Kanto Opioids Drug Consumption Share by End-Users in 2018

    • Figure Kanto Opioids Drug Consumption Share by End-Users in 2026

    • Table Chubu Opioids Drug Consumption by Types from 2014 to 2026

    • Table Chubu Opioids Drug Consumption Share by Types from 2014 to 2026

    • Figure Chubu Opioids Drug Consumption Share by Types in 2014

    • Figure Chubu Opioids Drug Consumption Share by Types in 2018

    • Figure Chubu Opioids Drug Consumption Share by Types in 2026

    • Table Chubu Opioids Drug Consumption by End-Users from 2014 to 2026

    • Table Chubu Opioids Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Opioids Drug Consumption Share by End-Users in 2014

    • Figure Chubu Opioids Drug Consumption Share by End-Users in 2018

    • Figure Chubu Opioids Drug Consumption Share by End-Users in 2026

    • Table Kinki Opioids Drug Consumption by Types from 2014 to 2026

    • Table Kinki Opioids Drug Consumption Share by Types from 2014 to 2026

    • Figure Kinki Opioids Drug Consumption Share by Types in 2014

    • Figure Kinki Opioids Drug Consumption Share by Types in 2018

    • Figure Kinki Opioids Drug Consumption Share by Types in 2026

    • Table Kinki Opioids Drug Consumption by End-Users from 2014 to 2026

    • Table Kinki Opioids Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Opioids Drug Consumption Share by End-Users in 2014

    • Figure Kinki Opioids Drug Consumption Share by End-Users in 2018

    • Figure Kinki Opioids Drug Consumption Share by End-Users in 2026

    • Table Chugoku Opioids Drug Consumption by Types from 2014 to 2026

    • Table Chugoku Opioids Drug Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Opioids Drug Consumption Share by Types in 2014

    • Figure Chugoku Opioids Drug Consumption Share by Types in 2018

    • Figure Chugoku Opioids Drug Consumption Share by Types in 2026

    • Table Chugoku Opioids Drug Consumption by End-Users from 2014 to 2026

    • Table Chugoku Opioids Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Opioids Drug Consumption Share by End-Users in 2014

    • Figure Chugoku Opioids Drug Consumption Share by End-Users in 2018

    • Figure Chugoku Opioids Drug Consumption Share by End-Users in 2026

    • Table Shikoku Opioids Drug Consumption by Types from 2014 to 2026

    • Table Shikoku Opioids Drug Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Opioids Drug Consumption Share by Types in 2014

    • Figure Shikoku Opioids Drug Consumption Share by Types in 2018

    • Figure Shikoku Opioids Drug Consumption Share by Types in 2026

    • Table Shikoku Opioids Drug Consumption by End-Users from 2014 to 2026

    • Table Shikoku Opioids Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Opioids Drug Consumption Share by End-Users in 2014

    • Figure Shikoku Opioids Drug Consumption Share by End-Users in 2018

    • Figure Shikoku Opioids Drug Consumption Share by End-Users in 2026

    • Table Kyushu Opioids Drug Consumption by Types from 2014 to 2026

    • Table Kyushu Opioids Drug Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Opioids Drug Consumption Share by Types in 2014

    • Figure Kyushu Opioids Drug Consumption Share by Types in 2018

    • Figure Kyushu Opioids Drug Consumption Share by Types in 2026

    • Table Kyushu Opioids Drug Consumption by End-Users from 2014 to 2026

    • Table Kyushu Opioids Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Opioids Drug Consumption Share by End-Users in 2014

    • Figure Kyushu Opioids Drug Consumption Share by End-Users in 2018

    • Figure Kyushu Opioids Drug Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of J&J

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of J&J

    • Figure Sales and Growth Rate Analysis of J&J

    • Figure Revenue and Market Share Analysis of J&J

    • Table Product and Service Introduction of J&J

    • Table Company Profile and Development Status of Vistapharm

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vistapharm

    • Figure Sales and Growth Rate Analysis of Vistapharm

    • Figure Revenue and Market Share Analysis of Vistapharm

    • Table Product and Service Introduction of Vistapharm

    • Table Company Profile and Development Status of Purdue Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Purdue Pharma

    • Figure Sales and Growth Rate Analysis of Purdue Pharma

    • Figure Revenue and Market Share Analysis of Purdue Pharma

    • Table Product and Service Introduction of Purdue Pharma

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Mylan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan

    • Figure Sales and Growth Rate Analysis of Mylan

    • Figure Revenue and Market Share Analysis of Mylan

    • Table Product and Service Introduction of Mylan

    • Table Company Profile and Development Status of Hikma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hikma

    • Figure Sales and Growth Rate Analysis of Hikma

    • Figure Revenue and Market Share Analysis of Hikma

    • Table Product and Service Introduction of Hikma

    • Table Company Profile and Development Status of INSYS

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of INSYS

    • Figure Sales and Growth Rate Analysis of INSYS

    • Figure Revenue and Market Share Analysis of INSYS

    • Table Product and Service Introduction of INSYS

    • Table Company Profile and Development Status of Endo

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Endo

    • Figure Sales and Growth Rate Analysis of Endo

    • Figure Revenue and Market Share Analysis of Endo

    • Table Product and Service Introduction of Endo

    • Table Company Profile and Development Status of Egalet

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Egalet

    • Figure Sales and Growth Rate Analysis of Egalet

    • Figure Revenue and Market Share Analysis of Egalet

    • Table Product and Service Introduction of Egalet

    • Table Company Profile and Development Status of Depomed

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Depomed

    • Figure Sales and Growth Rate Analysis of Depomed

    • Figure Revenue and Market Share Analysis of Depomed

    • Table Product and Service Introduction of Depomed

    • Table Company Profile and Development Status of Teva

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva

    • Figure Sales and Growth Rate Analysis of Teva

    • Figure Revenue and Market Share Analysis of Teva

    • Table Product and Service Introduction of Teva

    • Table Company Profile and Development Status of Pernix

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pernix

    • Figure Sales and Growth Rate Analysis of Pernix

    • Figure Revenue and Market Share Analysis of Pernix

    • Table Product and Service Introduction of Pernix

    • Table Company Profile and Development Status of Mallinckrodt

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mallinckrodt

    • Figure Sales and Growth Rate Analysis of Mallinckrodt

    • Figure Revenue and Market Share Analysis of Mallinckrodt

    • Table Product and Service Introduction of Mallinckrodt

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.